3Peleg AY, Husain S, Qureshi ZA, Silveira FP, Sarumi M, ShuttKA, Kwak EJ, Paterson DL. Risk factors, clinical characteristics,and outcome of Nocardia infection in organ transplant recipients:a matched case-control study. Clin Infect Dis 2007; 44: 1307-1314[PMID: 17443467 DOI: 10.1086/514340].
4Hardak E, Yigla M, Berger G, Sprecher H, Oren I. Clinicalspectrum and outcome of Nocardia infection: experience of 15-yearperiod from a single tertiary medical center. Am J Med Sci 2012; 343:286-290 [PMID: 21825961 DOI: 10.1097/MAJ.0b013e31822cb5dc].
6Brown-Elliott BA, Brown JM, Conville PS, Wallace RJ. Clinicaland laboratory features of the Nocardia spp. based on currentmolecular taxonomy. Clin Microbiol Rev 2006; 19: 259-282 [PMID:16614249 DOI: 10.1128/CMR.19.2.259-282.2006].
8Morelli J, Wilson FA. Does administration of infliximab increasesusceptibility to listeriosis- Am J Gastroenterol 2000; 95: 841-842[PMID: 10710107 DOI: 10.1111/j.1572-0241.2000.01872.x].
10Yamagata M, Hirose K, Ikeda K, Nakajima H. Clinicalcharacteristics of Nocardia infection in patients with rheumaticdiseases. Clin Dev Immunol 2013; 2013: 818654 [PMID: 24171035DOI: 10.1155/2013/818654].
